( August 26, 2025, 11:57 AM EDT) -- KANSAS CITY, Kan. — A federal magistrate in Kansas found that three related biopharmaceutical entities in a patent infringement dispute over the production of plant-derived recombinant human serum albumin (rHSA) must make supplemental responses to requests from another biopharmaceutical entity for certain discovery documents, holding that their objection to the motion to compel could not be squared with their claim to have supplied all responsive documents....